Presence of BRCA mutations and a pre-chemotherapy AMH level of < 2NG/ML strongly predict risk of amenorrhea in women with breast cancer için istatistikler
Toplam ziyaret
| views | |
|---|---|
| Presence of BRCA mutations and a pre-chemotherapy AMH level of < 2NG/ML strongly predict risk of amenorrhea in women with breast cancer | 8 |
Aylık toplam ziyaret
| views | |
|---|---|
| Ağustos 2025 | 0 |
| Eylül 2025 | 4 |
| Ekim 2025 | 0 |
| Kasım 2025 | 0 |
| Aralık 2025 | 1 |
| Ocak 2026 | 0 |
| Şubat 2026 | 0 |
Dosya Ziyaretleri
| views | |
|---|---|
| Presence of BRCA mutations and a pre_chemotherapy AMH level of 2NG_ML strongly predict risk of amenorrhea in women with breast cancer.pdf | 1 |
